Dr Chan Phetsouphanh – Immune dysfunction persists following mild-to-moderate SARS-CoV-2 infection

Event type: 
Event date: 
Tuesday, 15 February 2022 - 1:00pm to 2:00pm

Online event
Please click on the link just before the start of the webinar

Contact for inquiries: 
Rata Joseph, +61 (2) 9385 0900 or info@kirby.unsw.edu.au
Booking deadline: 



A proportion of patients surviving acute COVID-19 infection develop post-COVID syndrome (long COVID) encompassing physical and neuropsychiatric symptoms lasting longer than 12 weeks. The underlying pathophysiology of long COVID is poorly understood and there is currently little evidence defining the mechanisms of systemic inflammation following COVID-19 and any immune correlates of ongoing symptoms. Here, I describe a prospective cohort of individuals followed systematically post confirmed COVID-19 infection (the ADAPT study) and compared them to healthy donors and individuals contemporaneously infected with other non-SARS-CoV-2 human coronaviruses (ADAPT-C) to firstly characterise their immunological features up to 8 months post COVID-19 infection and secondly to compare those with and without persisting symptoms at this time point. 


Dr Chan Phetsouphanh  

Dr Chan Phetsouphanh
Senior Research Associate, Immunovirology and Pathogenesis Program, Kirby Institute

Chan Phetsouphanh recently returned to the Kirby Institute from his postdoctoral position at the University of Oxford (UK). His projects involve the investigation of T cell responses during SARS-CoV-2 infection and evaluating immune signatures of long COVID. He has keen interests in T cell biology, infectious diseases, virally driven cancers and immunopeptidomics.


Opinions expressed in the Kirby Institute Seminar Series are solely those of the speaker and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.